RalA and RalB are potential therapeutic targets in... (ID 523339) - BioProject

Format

Choose Destination

Accession: PRJNA523339 ID: 523339

RalA and RalB are potential therapeutic targets in multiple myeloma which mediate cell survival independently of oncogenic RAS (human)

See Genome Information for Homo sapiens

Navigate Across

NRAS and KRAS are frequently mutated oncogenic drivers in multiple myeloma, however, their use as drug targets has not been successful. More...

Accession	PRJNA523339; GEO: GSE126794
Data Type	Transcriptome or Gene expression
Scope	Multiisolate
Organism	Homo sapiens[Taxonomy ID: 9606] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
Submission	Registration date: 20-Feb-2019 Core Unit SysMed, University Hospital Würzburg
Relevance	Medical

Project Data:

Parameter	Value
Data volume, Supplementary Mbytes	4

Parameter	Value
Data volume, Gbases	16
Data volume, Mbytes	5391

Supplemental Content

RalA and RalB are potential therapeutic targets in multiple myeloma which mediat...
RalA and RalB are potential therapeutic targets in multiple myeloma which mediate cell survival independently of oncogenic RAS
RalA and RalB are potential therapeutic targets in multiple myeloma which mediate cell survival independently of oncogenic RAS

BioProject
freshwater metagenome
freshwater metagenome
Water column metagenomes from two Canadian Boreal Shield lakes

BioProject
Caenorhabditis elegans
Caenorhabditis elegans
TAIL-seq in cde-1 mutants versus WT C. elegans infected by the Orsay virus

BioProject
Mus musculus
Mus musculus
E.coli Infected Bladder Samples (PBS, WT and 2 mutants)

BioProject

Your browsing activity is empty.

Activity recording is turned off.